Ketamine: New Indications for an Old Drug

Author(s): M. G. Annetta, D. Iemma, C. Garisto, C. Tafani, R. Proietti

Journal Name: Current Drug Targets

Volume 6 , Issue 7 , 2005

Become EABM
Become Reviewer
Call for Editor


Ketamine is a non-competitive antagonist to the phencyclidine site of N-methyl-d-aspartate (NMDA) receptor for glutamate, though its effects are mediated by interaction with many others receptors. It has been introduced in clinical use since 1960s but today it is not largely employed as a general anaesthetic for its undesired psychic effects (emergence reactions) occurring in approximately 12% of patients. In the last decade, there has been a renewed interest in the use of subanaesthetic doses of ketamine for the treatment of acute and chronic pain. In the late 1990s, multiple prospective, randomised, controlled study has shown the efficacy of low dose of ketamine for postoperative pain relief, for analgesia during regional or local anaesthesia, and for opioid-sparing effect. At present, non-definitive conclusion can be drawn. More data are needed to define the possible long term effects and the clinical goal of ketamine use.

Keywords: ketamine, analgesia, opioids

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [789 - 794]
Pages: 6
DOI: 10.2174/138945005774574533
Price: $65

Article Metrics

PDF: 9